SALERNITANA | February 2019

By Goutham Rao, MD, FAHA
UH Chief Clinician Experience Officer

Goutham Rao, MD, FAHA

On behalf of Chief Academic Officer Dr. Mukesh Jain, I am pleased to provide details about two new research centers of excellence recently established at University Hospitals.

One is the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA). The CINEMA will be led Dr. Sanjay Rajagopalan, MD, Chief, Division of Cardiovascular Medicine, Department of Medicine at University Hospitals.

The center will leverage multiple pre-existing partnerships and collaborations within and outside of the institution to create an integrated, multidisciplinary program focused on better understanding and treatment of cardiac and vascular complications of Type 2 diabetes.

We anticipate that the CINEMA’s efforts will lead to development of better methods for detecting sub-clinical vascular disease, therapeutics for treatment and technology-based approaches to improve the lives of patients with diabetes and cardiovascular complications – including implementation science and personalized medicine.

The other is the Center of Excellence for Translational Neuro-Oncology (CETNO).

The CETNO will be led by Andrew E. Sloan, MD, the Peter D. Cristal Chair of Neurosurgical Oncology, Director, Brain Tumor and Neuro-Oncology Center and senior neurosurgeon at University Hospitals.

The CETNO will focus on critical challenges in neuro-oncology, such as the paucity and lack of specificity of biomarkers along with intra-tumoral heterogeneity that limit the clinician’s ability to understand and follow responses to brain tumor treatment. The Center will bring together multiple departments and centers at UH to create a unique platform to advance the understanding and treatment of brain tumors.